Robin has over 20 years of private equity experience in the US, Asia, the UK and France.
Robin started his career with Brown Brothers Harriman and, proceeding this, worked with the European group, Baring Private Equity Partners, in New York. Robin then participated in the launch of TCR Capital and then joined the Universities Superannuation Scheme pension fund.
Robin has completed a number of noteworthy transactions in the healthcare sector. He is currently a non-executive Director in the UK-headquartered Life Sciences consulting firm Deallus operating at global level, as well as in the UK-headquartered Occupational Health firm Vita Health, in the France-headquartered Health ingredients company Fytexia and in the Netherlands-based Operating Room supplier SMG.
Robin is a Founding Partner of ArchiMed, and is a Director of the Eureka Foundation, ArchiMed’s charitable foundation. Robin has a long-standing relationship with other ArchiMed partners, since 2007.
Robin graduated from the School of Foreign Service at Georgetown University, Washington, United States and holds an MBA from INSEAD. Robin is a British citizen.